Details of the Drug
General Information of Drug (ID: DMCKSX7)
Drug Name |
2-Morpholin-4-yl-pyrido[1,2-a]pyrimidin-4-one
|
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
CHEMBL179043; 2-(morpholin-4-yl)-4h-pyrido[1,2-a]pyrimidin-4-one; 17326-31-7; NSC110390; AC1Q6IJU; AC1L6MD6; 2-morpholin-4-ylpyrido[1,2-a]pyrimidin-4-one; 2-Morpholin-4-yl-pyrido[1,2-a]pyrimidin-4-one; SCHEMBL4544196; CTK4D4568; DTXSID80296606; ZINC1702791; BDBM50159642; AKOS024361168; NSC-110390; MCULE-7092692912; ST50991317
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Drug Type |
Small molecular drug
|
|||||||||||||||||||
Structure |
![]() |
|||||||||||||||||||
3D MOL | 2D MOL | |||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 231.25 | ||||||||||||||||||
Topological Polar Surface Area (xlogp) | 0.2 | |||||||||||||||||||
Rotatable Bond Count (rotbonds) | 1 | |||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 0 | |||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 4 | |||||||||||||||||||
Chemical Identifiers |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
References